{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:25:22Z","timestamp":1794536722320,"version":"4.9.1"},"reference-count":28,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Proinflammatory cytokines such as TNF\u03b1 are elevated in patients with myeloproliferative neoplasms (MPN), but their contribution to disease pathogenesis is unknown. Here we reveal a central role for TNF\u03b1 in promoting clonal dominance of JAK2V617F expressing cells in MPN. We show that JAK2V617F kinase regulates TNF\u03b1 expression in cell lines and primary MPN cells and TNF\u03b1 expression is correlated with JAK2V617F allele burden. In clonogenic assays, normal controls show reduced colony formation in the presence of TNF\u03b1 while colony formation by JAK2V617F-positive progenitor cells is resistant or stimulated by exposure to TNF\u03b1. Ectopic JAK2V617F expression confers TNF\u03b1 resistance to normal murine progenitor cells and overcomes inherent TNF\u03b1 hypersensitivity of Fanconi anemia complementation group C deficient progenitors. Lastly, absence of TNF\u03b1 limits clonal expansion and attenuates disease in a murine model of JAK2V617F-positive MPN. Altogether our data are consistent with a model where JAK2V617F promotes clonal selection by conferring TNF\u03b1 resistance to a preneoplastic TNF\u03b1 sensitive cell, while simultaneously generating a TNF\u03b1-rich environment. Mutations that confer resistance to environmental stem cell stressors are a recognized mechanism of clonal selection and leukemogenesis in bone marrow failure syndromes and our data suggest that this mechanism is also critical to clonal selection in MPN.<\/jats:p>","DOI":"10.1182\/blood-2011-04-348144","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T01:50:37Z","timestamp":1314064237000},"page":"6392-6398","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":286,"title":["TNF\u03b1 facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms"],"prefix":"10.1182","volume":"118","author":[{"given":"Angela G.","family":"Fleischman","sequence":"first","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Aichberger","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"},{"name":"Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel B.","family":"Luty","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Bumm","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis L.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Doratotaj","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Pediatrics, OHSU, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavin B.","family":"Vasudevan","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian H.","family":"LaTocha","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, OSHU, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Press","sequence":"additional","affiliation":[{"name":"Department of Pathology, OSHU, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M.","family":"Loriaux","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"},{"name":"Department of Pathology, OSHU, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike L.","family":"Pahl","sequence":"additional","affiliation":[{"name":"Center for Clinical Research, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Silver","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupriya","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"O'Hare","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Druker","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"},{"name":"Howard Hughes Medical Institute, Portland, OR; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grover C.","family":"Bagby","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR;"},{"name":"NW Cancer Research Center, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Deininger","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"23","key":"2019111816474207200_B1","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders.","volume":"355","author":"Campbell","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111816474207200_B2","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood-2009-12-259747","article-title":"JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.","volume":"116","author":"Li","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111816474207200_B3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells.","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"issue":"33","key":"2019111816474207200_B4","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1200\/JCO.2004.00.9316","article-title":"Pathogenesis of myelofibrosis with myeloid metaplasia.","volume":"23","author":"Tefferi","year":"2005","journal-title":"J Clin Oncol"},{"issue":"25","key":"2019111816474207200_B5","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1182\/blood-2009-05-223727","article-title":"CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms.","volume":"115","author":"Tyner","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2019111816474207200_B6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword.","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"2019111816474207200_B7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.194.7.941","article-title":"Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation.","volume":"194","author":"Bryder","year":"2001","journal-title":"J Exp Med"},{"issue":"6","key":"2019111816474207200_B8","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1182\/blood.V98.6.1782","article-title":"Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells.","volume":"98","author":"Dybedal","year":"2001","journal-title":"Blood"},{"issue":"45","key":"2019111816474207200_B9","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1038\/sj.onc.1208024","article-title":"Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cells.","volume":"23","author":"Beyne-Rauzy","year":"2004","journal-title":"Oncogene"},{"issue":"12","key":"2019111816474207200_B10","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.4049\/jimmunol.136.12.4487","article-title":"The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.","volume":"136","author":"Broxmeyer","year":"1986","journal-title":"J Immunol"},{"issue":"2","key":"2019111816474207200_B11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V69.2.467.467","article-title":"Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells.","volume":"69","author":"Murase","year":"1987","journal-title":"Blood"},{"issue":"8","key":"2019111816474207200_B12","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.4049\/jimmunol.178.8.5277","article-title":"Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice.","volume":"178","author":"Sejas","year":"2007","journal-title":"J Immunol"},{"issue":"11","key":"2019111816474207200_B13","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1172\/JCI31772","article-title":"TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells.","volume":"117","author":"Li","year":"2007","journal-title":"J Clin Invest"},{"issue":"9464","key":"2019111816474207200_B14","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"2019111816474207200_B15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2009.50","article-title":"CYT387, a selective JAK1\/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients.","volume":"23","author":"Pardanani","year":"2009","journal-title":"Leukemia"},{"issue":"8","key":"2019111816474207200_B16","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/sj.leu.2404750","article-title":"TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L\/K mutations.","volume":"21","author":"Pardanani","year":"2007","journal-title":"Leukemia"},{"issue":"23","key":"2019111816474207200_B17","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-06-2210","article-title":"Characterization of murine JAK2V617F-positive myeloproliferative disease.","volume":"66","author":"Bumm","year":"2006","journal-title":"Cancer Res"},{"key":"2019111816474207200_B18","first-page":"41","article-title":"The HL60 cell line: a model system for studying human myeloid cell differentiation.","volume":"9","author":"Birnie","year":"1988","journal-title":"Br J Cancer Suppl"},{"issue":"11","key":"2019111816474207200_B19","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1182\/blood.V91.11.4092","article-title":"Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac\u2212\/\u2212 mice.","volume":"91","author":"Haneline","year":"1998","journal-title":"Blood"},{"issue":"6","key":"2019111816474207200_B20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood-2010-02-270108","article-title":"Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.","volume":"116","author":"Oh","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111816474207200_B21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/leu.2008.229","article-title":"JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.","volume":"22","author":"Kilpivaara","year":"2008","journal-title":"Leukemia"},{"issue":"26","key":"2019111816474207200_B22","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1182\/blood-2009-05-222414","article-title":"TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells.","volume":"114","author":"Vanderwerf","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111816474207200_B23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ajh.2830420211","article-title":"Tumor necrosis factor-alpha overproduction in Fanconi's anemia.","volume":"42","author":"Schultz","year":"1993","journal-title":"Am J Hematol"},{"issue":"5","key":"2019111816474207200_B24","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood.V83.5.1216.1216","article-title":"Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha.","volume":"83","author":"Rosselli","year":"1994","journal-title":"Blood"},{"issue":"6","key":"2019111816474207200_B25","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood-2003-01-0114","article-title":"TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro.","volume":"102","author":"Dufour","year":"2003","journal-title":"Blood"},{"key":"2019111816474207200_B26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2741\/s167","article-title":"The stem cell fitness landscape and pathways of molecular leukemogenesis.","volume":"3","author":"Bagby","year":"2011","journal-title":"Front Biosci (Schol Ed)"},{"issue":"11","key":"2019111816474207200_B27","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/sj.leu.2401586","article-title":"Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.","volume":"13","author":"Lensch","year":"1999","journal-title":"Leukemia"},{"issue":"4","key":"2019111816474207200_B28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.","volume":"41","author":"Jones","year":"2009","journal-title":"Nat Genet"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/24\/6392\/1343995\/zh805011006392.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/24\/6392\/1343995\/zh805011006392.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T18:51:20Z","timestamp":1686250280000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/24\/6392\/29229\/TNF%CE%B1-facilitates-clonal-expansion-of-JAK2V617F"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,8]]},"references-count":28,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2011,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-04-348144","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,8]]}}}